1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Global Oncology Ablation Market Outlook: 2015-2020 (2nd Edition)

Global Oncology Ablation Market Outlook: 2015-2020 (2nd Edition)

  • December 2015
  • -
  • Meticulous Research
  • -
  • 172 pages

Oncology Ablation is the minimal invasive treatment that is used to destroy or inactive the cancer cells and tumors. The market for oncology ablation is on the rise due to increasing number of cancer diagnosis and high acceptance rate among the cancer community across the world. Over the traditional treatment, oncology ablation has many advantages as it is minimal invasive treatment that makes the recovery easy and quick; also it provides relief to patients who are reluctant to go for a surgery. Image guided ablation treatments promises the accuracy in destruction of tumor cells without damaging the uninfected cells. The research report titled “Global Oncology Ablation Market Outlook: 2015-2020” provides in-depth analysis of oncology ablation market in four major geographies. The report also emphasizes on the current trends in oncology ablation, market size, market share, recent developments, and forecasts till 2020.

The study offers a comprehensive analysis of oncology ablation market with respect to various technologies and type of cancer. The technologies analyzed in this report are radiofrequency ablation, microwave ablation, cryoablation, ethanol ablation, irreversible electroporesis (IRE), light (laser ablation), and ultrasound ablation; whereas, the cancer types analyzed in the report are lung cancer, liver cancer, breast cancer, kidney cancer, colorectal cancer and prostate cancer. Comprehensive geographical analysis of the oncology ablation is provided by segmenting the global market on the basis of major continents, namely, North America, Europe, Asia Pacific, and RoW (Rest of the World) which are further analyzed at a country level.

The report offers meticulous analysis of market dynamics, burning issues, and technological landscape of the global oncology ablation market. The report provides the competitive landscape of the major players in this market such as AngioDynamics (U.S.), Covidien (Ireland), Boston Scientific (U.S.), BSD Medical (U.S.), Galil Medical (U.S.), Misonix (U.S), Varian Medical Systems (U.S), Elekta AB (Sweden), Accuray .(U.S), HealthTronics (U.S.), Celon AG (Germany), NeuWave Medical (U.S.), SonaCare Medical (U.S), MedWaves Incorporated (U.S), RF Medical Co. (Korea), STARMed Co. (Korea), and APRO KOREA (Korea) with detailed analysis of their product portfolio, financials, and recent developments.


Key questions answered in the report-
Which are the high growth market segments in terms of technology and applications?
What are the market forecasts and estimates from the period 2015-2020?
What are the major drivers, restrains, threats, and opportunities in the global oncology ablation market?
What are the burning issues of the global oncology ablation market?
Who are the major suppliers/players in the global oncology ablation market and what share of the market do they hold?
What is the competitive landscape and who are the market leaders by sub-region in the global oncology ablation market?
What are the recent developments in the global oncology ablation market?
What are the different strategies adopted by the major players in the global oncology ablation market?
What are the local emerging players in different regions/ countries and how do they compete with the global players?
What are the geographical trends and high growth regions?

Table Of Contents

Global Oncology Ablation Market Outlook: 2015-2020 (2nd Edition)
1 Introduction to Global Oncology Ablation Market
1.1 Market Ecosystem
1.1.1 Technologies
1.1.2 Cancer Types
1.2 Report Elucidation
1.3 Market Buzz and Foreground
1.4 Research Methodology
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Market Analytics
2 Executive Summary
3 Market Insights
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Impact Analysis
3.6 Market Trends
3.7 Market Share Analysis
3.8 Technology Assessment
3.9 Products Assessment
3.9.1 Commercialized
3.9.2 Pipeline
3.10 Major Research Studies in Oncology Ablation
4 Global Oncology Ablation Market, By Technology
4.1 Radiofrequency Ablation
4.2 Microwave Ablation
4.3 Cryoablation
4.4 Ethanol Ablation
4.5 Irreversible Electroporesis (IRE)
4.6 Light (Laser Ablation)
4.7 Ultrasound
4.8 Others
5 Global Oncology Ablation Market, By Type Of Cancer
5.1 Liver Cancer
5.1.1 Primary Liver Cancer
5.1.1.1 Hepatocellular carcinoma (HCC)
5.1.1.2 Cholangiocarcinoma/Bile duct cancer
5.1.1.3 Angiosarcoma
5.1.2 Metastatic
5.2 Prostate Cancer
5.2.1 Acinar Adenocarcinoma
5.2.2 Ductal adenocarcinoma
5.2.3 Transitional cell (or urothelial) cancer
5.2.4 Squamous cell cancer
5.2.5 Carcinoid
5.2.6 Small cell cancer
5.2.7 Sarcomas and sarcomatoid cancers
5.3 Breast Cancer
5.3.1 Ductal carcinoma
5.3.2 Lobular carcinoma
5.3.3 Inflammatory
5.3.4 Triple-negative
5.3.5 Paget disease of the nipple
5.3.6 Phyllodes tumor
5.3.7 Angiosarcoma
5.4 Lung Cancer
5.4.1 Small cell lung cancer
5.4.2 Non small cell lung cancer
5.5 Kidney Cancer
5.6 Colorectal Cancer
6 Oncology Ablation Market, By Geography
6.1 North America
6.1.1 U.S.
6.1.2 Canada
6.2 Europe
6.2.1 Germany
6.2.2 France
6.2.3 U.K.
6.2.4 Italy
6.2.5 Spain
6.2.6 Russia
6.2.7 Rest of Europe
6.3 Asia-Pacific
6.3.1 China
6.3.2 India
6.3.3 Japan
6.3.4 Rest of Asia Pacific
6.4 Rest of the World
7 Competitive Landscape- Global Oncology Ablation Market
7.1 Agreements and Partnerships
7.2 Mergers and Acquisitions
7.3 New Product Launches
7.4 Expansions
7.5 Other Developments
8 Company Profiles
8.1 Accuray Inc.
8.1.1 Company Overview
8.1.2 Financials
8.1.3 Product Portfolio
8.1.4 Key Developments
8.2 AngioDynamics
8.2.1 Company Overview
8.2.2 Financials
8.2.3 Product Portfolio
8.2.4 Key Developments
8.3 APRO KOREA
8.3.1 Company Overview
8.3.2 Financials
8.3.3 Product Portfolio
8.3.4 Key Developments
8.4 Boston Scientific
8.4.1 Company Overview
8.4.2 Financials
8.4.3 Product Portfolio
8.4.4 Key Developments
8.5 BSD Medical
8.5.1 Company Overview
8.5.2 Financials
8.5.3 Product Portfolio
8.5.4 Key Developments
8.6 Celon AG (Olympus)
8.6.1 Company Overview
8.6.2 Financials
8.6.3 Product Portfolio
8.6.4 Key Developments
8.7 Covidien
8.7.1 Company Overview
8.7.2 Financials
8.7.3 Product Portfolio
8.7.4 Key Developments
8.8 Elekta AB
8.8.1 Company Overview
8.8.2 Financials
8.8.3 Product Portfolio
8.8.4 Key Developments
8.9 Galil Medical
8.9.1 Company Overview
8.9.2 Financials
8.9.3 Product Portfolio
8.9.4 Key Developments
8.10 HealthTronics Inc.
8.10.1 Company Overview
8.10.2 Financials
8.10.3 Product Portfolio
8.10.4 Key Developments
8.11 MedWaves Incorporated
8.11.1 Company Overview
8.11.2 Financials
8.11.3 Product Portfolio
8.11.4 Key Developments
8.12 Misonix Inc.
8.12.1 Company Overview
8.12.2 Financials
8.12.3 Product Portfolio
8.12.4 Key Developments
8.13 NeuWave Medical
8.13.1 Company Overview
8.13.2 Financials
8.13.3 Product Portfolio
8.13.4 Key Developments
8.14 RF Medical Co. Ltd
8.14.1 Company Overview
8.14.2 Financials
8.14.3 Product Portfolio
8.14.4 Key Developments
8.15 SonaCare Medical
8.15.1 Company Overview
8.15.2 Financials
8.15.3 Product Portfolio
8.15.4 Key Developments
8.16 STARMed Co. Ltd
8.16.1 Company Overview
8.16.2 Financials
8.16.3 Product Portfolio
8.16.4 Key Developments
8.17 Varian Medical Systems
8.17.1 Company Overview
8.17.2 Financials
8.17.3 Product Portfolio
8.17.4 Key Developments


List of Tables
Table 1 Global Oncology Ablation Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 2 Global Oncology Ablation Market Revenue, By Technology, 2015-2020 ($ Million)
Table 3 Global Radiofrequency Ablation Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 4 Global Microwave Ablation Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 5 Global Cryoablation Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 6 Global Ethanol Ablation Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 7 Global Irreversible Electroporesis (IRE) Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 8 Global Light (Laser Ablation) Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 9 Global Ultrasound Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 10 Global Others Technology Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 11 Global Oncology Ablation Market Revenue, By Type of Cancer, 2015-2020 ($ Million)
Table 12 Global Primary Liver Cancer Market Revenue, By Type, 2015-2020 ($ Million)
Table 13 Global Hepatocellular carcinoma (HCC) Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 14 Global Cholangiocarcinoma/Bile duct cancer Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 15 Global Angiosarcoma Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 16 Global Metastatic Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 17 Global Prostate Cancer Market Revenue, By Type, 2015-2020 ($ Million)
Table 18 Global Acinar Adenocarcinoma Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 19 Global Ductal adenocarcinoma Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 20 Global Transitional cell (or urothelial) cancer Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 21 Global Squamous cell cancer Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 22 Global Carcinoid Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 23 Global Small cell cancer Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 24 Global Sarcomas and sarcomatoid cancers Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 25 Global Breast Cancer Market Revenue, By Type, 2015-2020 ($ Million)
Table 26 Global Ductal carcinoma Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 27 Global Lobular carcinoma Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 28 Global Inflammatory Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 29 Global Triple-negative Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 30 Global Paget disease of the nipple Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 31 Global Phyllodes tumor Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 32 Global Angiosarcoma Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 33 Global Lung Cancer Market Revenue, By Type, 2015-2020 ($ Million)
Table 34 Global Small cell lung cancer Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 35 Global Non small cell lung cancer Market Revenue, By Country/Region, 2015-2020 ($ Million)
Table 36 Global Kidney Cancer Market Revenue, By Type, 2015-2020 ($ Million)
Table 37 Global Colorectal Cancer Market Revenue, By Type, 2015-2020 ($ Million)
Table 38 North America: Oncology Ablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 39 North America: Oncology Ablation Market Revenue, By Technology, 2015-2020 ($ Million)
Table 40 North America: Oncology Ablation Market Revenue, By Type of Cancer, 2015-2020 ($ Million)
Table 41 North America: Radiofrequency Ablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 42 North America: Microwave Ablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 43 North America: Cryoablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 44 North America: Ethanol Ablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 45 North America: Irreversible Electroporesis (IRE) Market Revenue, By Country, 2015-2020 ($ Million)
Table 46 North America: Light (Laser Ablation) Market Revenue, By Country, 2015-2020 ($ Million)
Table 47 North America: Ultrasound Market Revenue, By Country, 2015-2020 ($ Million)
Table 48 Europe: Oncology Ablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 49 Europe: Oncology Ablation Market Revenue, By Technology, 2015-2020 ($ Million)
Table 50 Europe: Oncology Ablation Market Revenue, By Type of Cancer, 2015-2020 ($ Million)
Table 51 Europe: Radiofrequency Ablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 52 Europe: Microwave Ablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 53 Europe: Cryoablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 54 Europe: Ethanol Ablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 54 Europe: Irreversible Electroporesis (IRE) Market Revenue, By Country, 2015-2020 ($ Million)
Table 55 Europe: Light (Laser Ablation) Market Revenue, By Country, 2015-2020 ($ Million)
Table 56 Europe: Ultrasound Market Revenue, By Country, 2015-2020 ($ Million)
Table 57 Asia - Pacific: Oncology Ablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 58 Asia - Pacific: Oncology Ablation Market Revenue, By Technology, 2015-2020 ($ Million)
Table 59 Asia - Pacific: Oncology Ablation Market Revenue, By Type of Cancer, 2015-2020 ($ Million)
Table 60 Asia - Pacific: Radiofrequency Ablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 61 Asia - Pacific: Microwave Ablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 62 Asia - Pacific: Cryoablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 63 Asia - Pacific: Ethanol Ablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 64 Asia - Pacific: Irreversible Electroporesis (IRE) Market Revenue, By Country, 2015-2020 ($ Million)
Table 65 Asia - Pacific: Light (Laser Ablation) Market Revenue, By Country, 2015-2020 ($ Million)
Table 66 Asia - Pacific: Ultrasound Market Revenue, By Country, 2015-2020 ($ Million)
Table 67 RoW: Oncology Ablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 68 RoW: Oncology Ablation Market Revenue, By Technology, 2015-2020 ($ Million)
Table 69 RoW: Oncology Ablation Market Revenue, By Type of Cancer, 2015-2020 ($ Million)
Table 70 RoW: Radiofrequency Ablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 71 RoW: Microwave Ablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 72 RoW: Cryoablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 73 RoW: Ethanol Ablation Market Revenue, By Country, 2015-2020 ($ Million)
Table 74 RoW: Irreversible Electroporesis (IRE) Market Revenue, By Country, 2015-2020 ($ Million)
Table 75 RoW: Light (Laser Ablation) Market Revenue, By Country, 2015-2020 ($ Million)
Table 76 RoW: Ultrasound Market Revenue, By Country, 2015-2020 ($ Million)
List Of Figures
Figure 1 Oncology Ablation Market Ecosystem
Figure 2 Research Methodology- Research Process
Figure 3 Research Methodology- Market Size Estimation
Figure 4 Research Methodology- Market Forecast
Figure 5 Research Methodology- Primary Research Sampling Frame
Figure 6 Oncology Ablation Market Size (USD Million), By Technology, 2015-2020
Figure 7 Oncology Ablation Market Size (USD Million), By Type Of Cancer, 2015-2020
Figure 8 Oncology Ablation Market Size (USD Million), By Geography, 2015-2020
Figure 9 Global Oncology Ablation Market: Market Drivers and Restraints (2014-2020)
Figure 10 Global Oncology Ablation Market Segmentation, By Technology
Figure 11 Global Oncology Ablation Market Segmentation, By Type Of Cancer
Figure 12 Global Penetration of Oncology Ablation (in %)
Figure 13 Share Of Key Strategies in the Global Oncology Ablation Market (2013-2015)
Figure 14 AngioDynamics: Total Revenue, 2012-2014 (In USD Million)
Figure 15 AngioDynamics: Total Revenue, By Region, 2014 (In USD Million)
Figure 16 AngioDynamics: Total Revenue, By Business Segments, 2014 (In USD Million)
Figure 17 Boston Scientific Corporation: Total Revenue, 2012-2014 (In USD Million)
Figure 18 Boston Scientific Corporation: Total Revenue, By Region, 2014 (In USD Million)
Figure 19 Boston Scientific Corporation: Total Revenue, By Business Segments, 2014 (In USD Million)
Figure 20 Accuray Inc.: Total Revenue, 2012-2014 (In USD Million)
Figure 21 Accuray Inc.: Total Revenue, By Region, 2014 (In USD Million)
Figure 21 Accuray Inc.: Total Revenue, By Business Segments, 2014 (In USD Million)
Figure 22 Elekta AB: Total Revenue, 2012-2014 (In USD Million)
Figure 23 Elekta AB: Total Revenue, By Region, 2014 (In USD Million)
Figure 24 Elekta AB: Total Revenue, By Business Segments, 2014 (In USD Million)
Figure 25 Varian Medical Systems: Total Revenue, 2012-2014 (In USD Million)
Figure 26 Varian Medical Systems: Total Revenue, By Region, 2014 (In USD Million)
Figure 27 Varian Medical Systems: Total Revenue, By Business Segments, 2014 (In USD Million)


Companies Mentioned
Accuray Inc.
AngioDynamics
APRO KOREA
Boston Scientific
BSD Medical
Celon AG (Olympus)
Covidien
Elekta AB
Galil Medical
HealthTronics Inc.
MedWaves Incorporated
Misonix Inc.
NeuWave Medical
RF Medical Co. Ltd
SonaCare Medical
STARMed Co. Ltd
Varian Medical Systems

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Brain Cancer: Analytical Tool

August 2016 $ 8096

Breast Cancer: Analytical Tool

August 2016 $ 8096

Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the UK

  • November 2016
    10 pages
  • Cancer  

  • United Kingdom  

View report >

Cervical Cancer Statistics

  • November 2016
    6 pages
  • Cervical Cancer  

    Vaccine  

    HPV Vaccine  

View report >

Pollution Control Statistics in the US

  • November 2016
    218 pages
  • Pollution Contr...  

    Cancer  

    Metals  

  • United States  

    North America  

View report >

Related Market Segments :

Cancer
Digestive System Disorder
Oncology

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.